years after transplantation for groups A and B with respect was 21. 8 or mycophenolate mofetil (1.5g/day), methylpredonisolone (1mg/kg/day) , and antilymphocyte globulin was used in addition to CNI.
Shortly before transplantation , cortical wedge biopsy of the graft was performed. At approximately 3M and also at 3 years after transplantation, core needle biopsy was performed using a Biopty gun (16G ; CR Bard , Covington , GA) under ultrasonographic guidance, with the patient's or parent's informed consent as appropriate for age. Biopsy specimens were evaluated by two observers according to the Banff working classification in a blinded fashion.
We excluded samples from cases with an episode of acute rejection or CNI toxicity. Acute rejection was diagnosed by an increase in serum creatinine exceeding 30% ; whenever possible , an additional core needle biopsy specimen was obtained to confirm the diagnosis. Of 40 patients 21 could be followed up Anti-ET antibody staining was seen in tubular epithelium, but little staining was seen in glomeruli ( Fig. 1) . 21.6% respectively (Table. 3). Thus, graft function worsed significantly more when ET immunoreactivity was high(p<0.05).
Recently, graft survival after transplantation has improved steadily as a result We examined ET immunoreactivity in biopsy specimens at 3M after transplantation, correlating ET expression with change in graft function between 3M and 3Y after transplantation. Since a caderveric donor kidney is subjected to varying degrees of warm and cold ischemia causing ischemia -reperfusion injury that may lead to acute tubular necrosis 9 , we excluded caderveric grafts from study.
We first compared ET expression, pretransplantation allograft specimens with expression in 3M allograft specimens. We found ET expression at 3M to be significantly higher than during the pretransplantion period. In addition to ischemia and rejection , immunosuppressive therapy can contribute to allograft injury ; CNI is reported to stimulate ET expression 4,10,11 . However , we found no significant differences in trough CNI concentration between groups with minimal and strong ET expression.
Group B grafts, with strong ET expression, showed significantly more rapid decline in graft function at 3Y. In 10 of 13 cases(group A), and 5 of 8 cases(group B), protocol biopsy at 3Y were performed. So 1 case(10%) in group A and 4 cases(80%) in group B showed biopsyproven CAN. Our findings suggest that ET expression in early posttransplantion biopsy specimens is related to long-term allograft function in living related renal transplantation.
We also examined relationships between immunohistochemically evident ET expression and hypertension at 3Y after transplantation, finding no association between ET expression at 3M and at 3Y in ET expression , or between ET expression at 3M and subsequent hypertension. Uninary ET-1 concentration at 10 days after transplantation or later have been reported to be similar to findings in a the control group 11 . Thus urinary ET-1 excretion is regulated as opposed to being simply flow dependent. In a study in rats, an oral ET receptor antagonist was found to prevent CAN 3 . Our results suggest that amount of ET expression in an early biopsy specimen from the graft has prognostic significance, and that modifying ET effects might indeed represent a new strategy for preventing CAN.
